Start your intake Brello and the tirzepatide question Zepbound is a brand of tirzepatide, a GIP/GLP-1 dual agonist
Researchers found that Foundayo had a side-effect profile similar to other GLP-1 medications, with most issues being mild to moderate digestive problems
Promotes Cardiovascular & Metabolic Health Helps support heart health, insulin sensitivity, and metabolic balance
After 12 weeks on the higher dose (15 mg/92 mg) , if patients have not achieved at least 5% weight loss from baseline, discontinuation is advised as further benefit is unlikely
Focus on incorporating all essential food groups into your meals, including fruits, vegetables, lean proteins, whole grains, and healthy fats